Creighton University School of Medicine Distinguished Lecture Series

Creighton University School of Medicine Distinguished Lecture Series
Wednesday, December 5, 2018 - 12:00pm - 1:00pm

Amygdala Plasticity and Pain

Volker Neugebauer, MD, PhD, is Professor and Chair of the Department of Pharmacology and Neuroscience at the Texas Tech University Health Sciences Center, where he also holds the Giles McCrary Endowed Chair in Addiction Medicine and serves as Founding Director of the Center of Excellence for Translational Neuroscience and Therapeutics.

Designed For

Physicians, physicians assistants, nurses, nurse practitioners, residents, fellows and students

Provided By

Creighton University School of Medicine
Department of Pharmacology
Creighton University Office of Continuing Education

Objectives

  • Appreciate that pain as a multidimensional experience engages brain centers of emotions such as the amygdala.
  • Understand the concept of neuroplasticity in the amygdala as a pain mechanism.
  • Know about strategies for the mechanistic analysis of a causal relationship between brain/neural circuit activity and pain-related behaviors.

Presented By Volker Neugebauer, MD, PhD

Volker Neugebauer, MD, PhD, is Professor and Chair of the Department of Pharmacology and Neuroscience at the Texas Tech University Health Sciences Center, where he also holds the Giles McCrary Endowed Chair in Addiction Medicine and serves as Founding Director of the Center of Excellence for Translational Neuroscience and Therapeutics. The focus of Dr. Neugebauer’s research over the past two decades has been on synaptic and cellular mechanisms of higher brain functions and dysfunctions in pain conditions and neuropsychiatric disorders. Dr. Neugebauer pioneered the field of pain-related neuroplasticity in the amygdala, a brain center for emotions. The analysis of emotional-affective and cognitive brain mechanisms of pain centered on the amygdala and cortico-limbic interactions is a key contribution of his work to the field of pain research and neuroscience. Through collaborative research projects his team explores brain mechanisms of alcohol abuse and addiction disorders, comorbidities with depression and anxiety disorders, neurodegenerative disorders, and epileptogenesis. Dr. Neugebauer’s research program uses a multidisciplinary approach to integrate state-of-the-art systems and slice electrophysiology, multi-photon imaging in vivo and ex vivo, microendoscopy for in vivo calcium imaging, optogenetics, viral vector strategies, pharmacology and innovative behavioral assays. Dr. Neugebauer’s research has been funded by NIH continuously since 1999. He also has a track record of successful mentoring of junior faculty, postdoctoral trainees, and graduate and medical students. 


Education Credit

Category 1
Creighton University Health Sciences Continuing Education designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurse CE
Creighton University Health Sciences Continuing Education designates this activity for 1.0 contact hours for nurses. Nurses should claim only credit commensurate with the extent of their participation in the activity.

Accreditation Statement

In support of improving patient care, Creighton University Health Sciences Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CHI Health Creighton University Medical Center Bergan Mercy
7710 Mercy Road
Room 11661 A, B and C
Omaha, NE 68124
United States